The utility of general purpose versus specialty clinical databases for research: warfarin dose estimation from extracted clinical variables.
other · Level V
Where this comes from
- Record sourced from PubMed, PMID 20363365.
- Also identified by DOI 10.1016/j.jbi.2010.03.014 and PMC identifier 2928873.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
There is debate about the utility of clinical data warehouses for research. Using a clinical warfarin dosing algorithm derived from research-quality data, we evaluated the data quality of both a general-purpose database and a coagulation-specific database. We evaluated the functional utility of these repositories by using data extracted from them to predict warfarin dose. We reasoned that high-quality clinical data would predict doses nearly as accurately as research data, while poor-quality clinical data would predict doses less accurately. We evaluated the Mean Absolute Error (MAE) in predicted weekly dose as a metric of data quality. The MAE was comparable between the clinical gold standard (10.1mg/wk) and the specialty database (10.4 mg/wk), but the MAE for the clinical warehouse was 40% greater (14.1mg/wk). Our results indicate that the research utility of clinical data collected in focused clinical settings is greater than that of data collected during general-purpose clinical care.
Medical subject headings
- Anticoagulants
- Biopharmaceutics
- Databases, Factual
- Drug Dosage Calculations
- Medical Informatics
- Warfarin